Pediatric Segment Growth Continues at 36% CAGR MINNEAPOLIS, June 14, 2022 (GLOBE NEWSWIRE) — Improving access to life-saving fluid management therapies is a commitment by which Nuwellis, Inc. (Nasdaq: NUWE) stands. The company today announced its Aquadex SmartFlow® system is now available at two new pediatric hospitals in Florida and Arkansas. “By […]
Other News
AnaBios Further Expands Business Development Team With Hiring of Dr. Blake Anson
SAN DIEGO, June 14, 2022 (GLOBE NEWSWIRE) — AnaBios is pleased to announce the hire of Blake Anson, Ph.D., as Vice President of Business Development. In this new role, Dr. Anson will contribute to AnaBios’ global growth of its contract research outreach. Dr. Anson joins AnaBios from Stemonix (now part […]
Vascular Quality Initiative (SVS VQI) Announces the Expansion of Medicare Coverage to Standard Surgical Risk Patients within their TCAR Surveillance Project
CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revascularization (TCAR) to include standard surgical risk patients within the VQI […]
Fauna Bio’s Comparative Genomics Approach Finds New Compounds for Heart and Lung Diseases
Partnerships with top institutions move leading candidates into pre-clinical evaluation; platform updates enable discovery of new targets EMERYVILLE, Calif., June 14, 2022 /PRNewswire/ — Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, is celebrating its fourth birthday this month with the release of Centaur, a knowledge graph that is […]
HeartLab Unveils Pulse 2.0, An Efficient Cardiology Imaging Platform, at ASE Scientific Sessions 2022
Pulse is a cloud platform for cardiac imaging that streamlines reporting workflows to help cardiologists be more efficient AUCKLAND, New Zealand, June 13, 2022 /PRNewswire/ — HeartLab, the creator of Pulse — a cloud platform to help clinicians streamline reporting workflows — today announced the US launch of Pulse 2.0 at the American Society […]
Genesis Foundation and SBI Foundation together save a 2-month-old baby from heart failure
THANE, India, June 13, 2022 /PRNewswire/ — Two–month–old, Sakshi (name changed) had a hole in her heart called the Aorta Pulmonary Window. With extreme respiratory distress, the child would not have survived infancy if she had not received timely treatment, with financial support from SBI Foundation, through Genesis Foundation. With a weight of 2.9 kilograms, […]
Ablative Solutions, Inc. Announces Completion of the Fourth Tranche of its Series D Preferred Financing Round for Unique Therapeutic Approach to Treating Uncontrolled Hypertension
WAKEFIELD, Mass., June 13, 2022 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches to the treatment of hypertension, today announced the completion of the fourth tranche of its Series D financing round, resulting in $91.4 million in aggregate proceeds to the Company from the Series D financing round. Gilde Healthcare, BioStar Capital, Invus […]
Shimadzu Medical Systems announces Release of New Angiography System at the SIR 2022
TORRANCE, Calif., June 12, 2022 /PRNewswire/ — Shimadzu Corporation will commence worldwide sales of its flagship newest version of its Trinias™ angiography system. Shimadzu Medical Systems USA will introduce our innovative new technology solutions in angiography at the SIR 2022 conference, starting on Sunday, June 12, 2022. The new Trinias system uses AI deep learning […]
Philips announces positive three-year clinical research results from its Tack Optimized Balloon Angioplasty (TOBA) II below-the-knee (BTK) clinical trial
For below-the-knee arterial dissection repair following balloon angioplasty, innovative medical technology shows sustained treatment effect and positive impact on quality of life for patients with critical limb ischemia (CLI) First and only FDA-approved device of its kind demonstrates consistently high rates of target limb salvage (93.9%) and freedom from clinically-driven […]
Keros Therapeutics Presents Results from a Preclinical Study of RKER-012 in Pulmonary Arterial Hypertension at the Pulmonary Hypertension Association International Conference and Scientific Sessions
LEXINGTON, Mass., June 13, 2022 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced results from a preclinical […]



